“The incidence of thrombotic events is three-fold to four-fold higher in patients with IBD compared with patients without IBD,” notes Alfred D. Nelson, MD. However, while some research from the National Inpatient Sample (NIS)—the most extensive publicly available all-payer inpatient database in the United States—has assessed this association, stratification for Crohn’s disease and ulcerative colitis in bigger studies is limited, according to the study results.
Author: Abhay Panchal
PLYMOUTH, Minn., June 6, 2023 /PRNewswire/ — GIE Medical, a clinical stage company developing solutions for patients suffering from benign stricture(s) of the esophagus or bowel, was granted designation as a Breakthrough Device from the U.S. Food and Drug Administration (FDA) for its ProTractX3™ TTS DCB indicated for dilation of recurrent benign esophageal strictures in adults with obstructive symptoms associated with narrowing of the esophagus. In December 2022, GIE Medical launched two large, multicenter randomized controlled clinical trials in the United States to investigate the company’s first of its kind multi-stage drug-coated balloon (DCB) technology, ProTractX3 TTS DCB.
Oncology is seen as an early adopter of machine learning in healthcare, and as a doctor who has been working in medical oncology for over a decade, I have seen firsthand how technology has advanced the field. Now, I work at a computer vision company that is using artificial intelligence (AI) in gastroenterology and although these areas of medicine differ, I am struck by the similarities in opportunities that technology has to help advance care and improve outcomes for patients afflicted by diseases in both fields.
CUPERTINO, CALIFORNIA Apple today announced new health features in iOS 17, iPadOS 17, and watchOS 10, expanding into two impactful areas and providing innovative tools and experiences across platforms. New mental health features allow users to log their momentary emotions and daily moods, see valuable insights, and easily access assessments and resources. iPhone, iPad, and Apple Watch offer new vision health features that encourage healthy behaviors that help reduce the risk of myopia, and the Health app comes to iPad, giving users new ways to see their health data. All of these new features — and existing health features —…
With pandemic protections guaranteeing Medicaid coverage now gone, many states have begun unenrolling certain individuals — a process that could lead around 15 million people to lose coverage over the next year. A deep dive into the end of the COVID PHE Millions of Americans could lose Medicaid coverageIn 2020, states that received enhanced Medicaid funding were prohibited from dropping individuals from the program during the COVID-19 public health emergency. During the pandemic, Medicaid enrollment increased significantly, and over 91 million people were enrolled in either Medicaid or CHIP as of October. However, the continuous coverage requirement recently ended on…
In March, insurer UnitedHealthcare announced changes to prior authorization for certain GI procedures. The night before changes were to take effect on June 1, UHC reversed the plan, opting instead for an advanced notification alternative. The new plan requires gastroenterologists to submit certain patient data, which it will collect for future use in a “gold card” program, set to launch in 2024. Gastroenterologist Linda Lee, MD, medical director of endoscopy at Boston-based Brigham and Women’s Hospital and associate professor of medicine at Boston’s Harvard Medical School, says that gastroenterologists should be leery of UHC’s prior authorization alternative.
G&H How common are endoscopic recurrence and clinical recurrence of Crohn’s disease following surgery? MR The simple answer is that both are common. Endoscopic recurrence refers to the appearance of ulcerations or inflammation representing Crohn’s disease on colonoscopy, usually within the first year after surgical treatment. Historically, in patients with Crohn’s disease who have been treated with surgery and have not started a postoperative medication, endoscopic recurrence has been reported in up to 90%, which is quite high. Clinical recurrence, on the other hand, involves the return of symptoms that represent active Crohn’s disease, and often a complication such as…
The gut microbiome, or the colony of bacteria living inside our colon, might be an important key to help determine whether a young person will develop colon cancer, a new study suggests. Scientists have known certain bacteria can disturb the lining of the colon, which may result in the formation of tumors and the development of cancer. Building upon this, researchers at Georgetown University set out to find which bacteria strains are more present in the guts of young people who develop colon cancer.
Healthcare is advancing more swiftly by the year with new technologies, treatment options and artificial intelligence models hitting hospitals across the world. With the acceleration of advancements, it is hard to imagine how the industry will change. While some believe racial equity challenges might remain, others expect personalized care by genomics to be the standard and that there will be medications that will prevent disease before it takes root. Becker’s asked eight leaders to speculate on what healthcare might look like in 2123: Tony Ambrozie. Senior Vice President and Chief Digital and Information Officer of Baptist Health South Florida (Coral…
June 2 (Reuters) – Cancer test maker Grail Inc (GRAL.O) said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail’s flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc (ILMN.O), said the letters were mistakenly sent by PWNHealth due to a software issue and that it “was in no way related to or caused by an incorrect Galleri test result”.